During the past decade, Ann M Wierman MD LTD conducted 112 clinical trials. In the 10-year time frame, 112 clinical trials started and 31 clinical trials were completed, i.e. on average, 27.7% percent of trials that started reached the finish line to date. In the past 5 years, 40 clinical trials started and 30 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ann M Wierman MD LTD" #1 sponsor was "National Cancer Institute (NCI)" with 57 trials, followed by "Alliance for Clinical Trials in Oncology" with 22 trials sponsored, "SWOG Cancer Research Network" with 22 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 13 trials sponsored and "NRG Oncology" with 13 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ann M Wierman MD LTD" #1 collaborator was "National Cancer Institute (NCI)" with 63 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Ann M Wierman MD LTD" are "Invasive Breast Carcinoma" (6 trials), "Recurrent Squamous Cell Lung Carcinoma" (6 trials), "Stage IV Lung Cancer AJCC v8" (6 trials), "Recurrent Lung Non-Small Cell Carcinoma" (5 trials) and "Stage IIIA Breast Cancer" (5 trials). Many other conditions were trialed in "Ann M Wierman MD LTD" in a lesser frequency.

Most popular intervention types in "Ann M Wierman MD LTD" are "Drug" (97 trials), "Other" (71 trials), "Biological" (50 trials), "Procedure" (38 trials) and "Radiation" (12 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (27 trials), "Quality-of-Life Assessment" (27 trials), "Computed Tomography" (24 trials), "Biospecimen Collection" (23 trials) and "Nivolumab" (20 trials). Other intervention names were less common.

The vast majority of trials in "Ann M Wierman MD LTD" are 109 trials for "All" genders, 11 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Ann M Wierman MD LTD". undefined are not yet recruiting, 41 are recruiting, 60 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Ann M Wierman MD LTD, 4 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Ann M Wierman MD LTD, 2 "Phase 1" clinical trials were conducted, 64 "Phase 2" clinical trials and 56 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".